Real-world economic burden of disease recurrence in patients with muscle-invasive bladder cancer: A population-level claims-based analysis.
Saved in:
| Title: | Real-world economic burden of disease recurrence in patients with muscle-invasive bladder cancer: A population-level claims-based analysis. |
|---|---|
| Authors: | Squires P; Merck & Co., Inc., Rahway, NJ., Cook EE; Analysis Group, Inc., Boston, MA., Song Y; Analysis Group, Inc., Boston, MA., Wang CY; Merck & Co., Inc., Rahway, NJ., Jiang AX; Analysis Group, Inc., Boston, MA., Zhang A; Analysis Group, Inc., Boston, MA., Seshasayee SM; Analysis Group, Inc., Boston, MA., Rogiers A; Merck & Co., Inc., Rahway, NJ., Li H; Merck & Co., Inc., Rahway, NJ., Mamtani R; Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia. |
| Source: | Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2025 Dec; Vol. 31 (12), pp. 1248-1258. Date of Electronic Publication: 2025 Sep 17. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
